A detailed history of Great West Life Assurance CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 126,196 shares of REGN stock, worth $93.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
126,196
Previous 120,091 5.08%
Holding current value
$93.1 Million
Previous $126 Million 5.2%
% of portfolio
0.23%
Previous 0.24%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1024.09 - $1201.76 $6.25 Million - $7.34 Million
6,105 Added 5.08%
126,196 $133 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $16.7 Million - $20.3 Million
18,927 Added 18.71%
120,091 $126 Million
Q1 2024

May 13, 2024

SELL
$902.69 - $993.35 $9.77 Million - $10.8 Million
-10,824 Reduced 9.67%
101,164 $97.4 Million
Q4 2023

Feb 13, 2024

SELL
$775.18 - $881.7 $8.82 Million - $10 Million
-11,375 Reduced 9.22%
111,988 $97.8 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $163,418 - $199,271
-236 Reduced 0.19%
123,363 $101 Million
Q2 2023

Aug 10, 2023

SELL
$700.03 - $830.35 $5.77 Million - $6.84 Million
-8,241 Reduced 6.25%
123,599 $89.3 Million
Q1 2023

May 12, 2023

SELL
$680.49 - $826.97 $8.43 Million - $10.2 Million
-12,386 Reduced 8.59%
131,840 $108 Million
Q4 2022

Feb 10, 2023

SELL
$705.89 - $766.39 $17.6 Million - $19.1 Million
-24,961 Reduced 14.75%
144,226 $105 Million
Q3 2022

Nov 01, 2022

BUY
$573.97 - $724.32 $97.1 Million - $123 Million
169,187 New
169,187 $116 Million
Q2 2022

Aug 09, 2022

BUY
$548.35 - $738.84 $2.4 Million - $3.23 Million
4,377 Added 2.54%
176,654 $105 Million
Q1 2022

May 12, 2022

SELL
$595.12 - $698.43 $974,211 - $1.14 Million
-1,637 Reduced 0.94%
172,277 $127 Million
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $8.96 Million - $11.1 Million
16,481 Added 10.47%
173,914 $110 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $2.67 Million - $3.17 Million
4,654 Added 3.05%
157,433 $95.8 Million
Q2 2021

Aug 11, 2021

SELL
$472.8 - $558.54 $11.4 Million - $13.5 Million
-24,151 Reduced 13.65%
152,779 $85.3 Million
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $5.46 Million - $6.7 Million
-12,222 Reduced 6.46%
176,930 $83.3 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $19.5 Million - $24.8 Million
40,758 Added 27.47%
189,152 $91.2 Million
Q3 2020

Nov 17, 2020

SELL
$544.75 - $658.21 $7.48 Million - $9.04 Million
-13,729 Reduced 8.47%
148,394 $83.1 Million
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $17.4 Million - $21.1 Million
32,002 Added 24.59%
162,123 $90.8 Million
Q2 2020

Aug 17, 2020

BUY
$493.32 - $643.92 $32.5 Million - $42.5 Million
65,976 Added 102.85%
130,121 $80.7 Million
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $5.55 Million - $8.16 Million
-16,507 Reduced 20.47%
64,145 $31.5 Million
Q4 2019

Feb 11, 2020

BUY
$274.13 - $376.51 $981,111 - $1.35 Million
3,579 Added 4.64%
80,652 $30.3 Million
Q3 2019

Oct 25, 2019

SELL
$273.46 - $318.39 $1.98 Million - $2.3 Million
-7,237 Reduced 8.58%
77,073 $21.4 Million
Q2 2019

Jul 31, 2019

BUY
$299.6 - $414.82 $116,244 - $160,950
388 Added 0.46%
84,310 $0
Q1 2019

May 08, 2019

BUY
$372.08 - $439.57 $6.68 Million - $7.89 Million
17,957 Added 27.22%
83,922 $34.4 Million
Q4 2018

Feb 12, 2019

BUY
$335.82 - $403.04 $5.66 Million - $6.8 Million
16,865 Added 34.35%
65,965 $23.8 Million
Q3 2018

Nov 13, 2018

SELL
$351.14 - $408.51 $2.65 Million - $3.09 Million
-7,559 Reduced 13.34%
49,100 $19.9 Million
Q2 2018

Aug 10, 2018

BUY
$284.6 - $344.99 $262,970 - $318,770
924 Added 1.66%
56,659 $19.5 Million
Q1 2018

May 10, 2018

SELL
$315.82 - $393.78 $4.87 Million - $6.08 Million
-15,436 Reduced 21.69%
55,735 $19.2 Million
Q4 2017

Feb 09, 2018

BUY
$358.63 - $469.95 $1.66 Million - $2.18 Million
4,635 Added 6.97%
71,171 $26.7 Million
Q3 2017

Nov 09, 2017

BUY
$431.38 - $504.0 $28.7 Million - $33.5 Million
66,536
66,536 $29 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.